We immunoprofiled T cell populations in the DLN and TILs at day 4, the time at which we observed decreases in circulating lymphocytes, at day 7, and at day 9, the time at which we observed expansion of tumor antigen–specific CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.